liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Frequent promoter methylation of tumor-related genes in sporadic and men2-associated pheochromocytomas
Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany.
Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany.
Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany.
Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany.
Show others and affiliations
2005 (English)In: Experimental and clinical endocrinology & diabetes, ISSN 0947-7349, E-ISSN 1439-3646, Vol. 113, no 1, 1-7 p.Article in journal (Refereed) Published
Abstract [en]

Hypermethylation of CpG island promoters is associated with transcriptional inactivation of tumor suppressor genes in neoplasia. Inactivation of p16 and Pten was related to the development of pheochromocytomas. In this report, we investigated the methylation status of the p16INK4a cell cycle inhibitor gene and other prominent tumor-related genes ( PTEN, RASSF1 A, CDH1, MSH2, MLH1, VHL, and TIMP3) in sporadic and multiple endocrine neoplasia type 2 (MEN2) pheochromocytomas by methylation-specific PCR. Hypermethylation was detected in 48 % of pheochromocytomas for RASSF1 A, 24 % for p16, 36 % for MSH2, 16 % for CDH1, and 8 % for PTEN. No VHL, MLH1, and TIMP3 methylation was observed. Interestingly, the frequency of p16 inactivation in familial tumors was higher (5 out of 12, 42 %) than in sporadic tumors (1 out of 13, 8 %; p = 0.047) and RASSF1 A inactivation was more common in the hereditary tumors (58 %) compared to the sporadic tumors (38 %). Combined methylation of RASSF1 A and p16 was found only in MEN2-related pheochromocytomas. Thus, a subset of hereditary pheochromocytomas displays preferential methylation of p16 and RASSF1 A.

Place, publisher, year, edition, pages
2005. Vol. 113, no 1, 1-7 p.
Keyword [en]
Pheochromocytoma - multiple endocrine neoplasia type 2 - methylation - tumor suppressor gene
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-101412DOI: 10.1055/s-2004-830522PubMedID: 15662588OAI: oai:DiVA.org:liu-101412DiVA: diva2:666145
Available from: 2013-11-22 Created: 2013-11-22 Last updated: 2017-12-06Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Authority records BETA

Gimm, Oliver

Search in DiVA

By author/editor
Gimm, Oliver
In the same journal
Experimental and clinical endocrinology & diabetes
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 28 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf